Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...
Singapore will begin providing subsidies and allow individuals to use their personal medical savings for shingles ...
SINGAPORE, Feb. 11 (Xinhua) -- Singapore will begin providing subsidies and allow individuals to use their personal medical savings for shingles ... percent for Shingrix, the only vaccine ...
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.
The proceeds were earmarked for the ongoing phase 1/1b StrateGIST 1 trial of the selective KIT inhibitor in patients with KIT-mutant GIST who have failed prior treatment with Novartis Gleevec ...
Looking at its other vaccine products, GSK's top-selling shingles vaccine Shingrix also declined 7% ... and new MenABCWY meningitis jab. The day before the results announcement, GSK revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results